Tuesday, 8 August 2017

DNA Damage Induced by Ultrasound and Cellular Responses

Ultrasonic technologies pervade the medical field as a long established imaging modality in clinical diagnostics and, with the emergence of targetedhigh-intensity focused ultrasound, as a means of thermally ablating tumors.

Ultrasound (US) causes multiple thermal and non-thermal effects, such as mechanical and chemical stresses, that can result in damage to the cellular membrane and nucleus, leading to transient membrane pores, alterations in gene expression, and cell death, including apoptosis. On the basis of its biological effects US has been proposed as a new drug delivery and molecular targeting tool for cancer therapy. However, the molecular mechanisms involved in US induced cell killing are not yet fully understood. Recently, we have reported that the mechanical effects of US elicit DNA single strand as well as double strand breaking- the most cytotoxic form of DNA damage, which initiates subsequent DNA damage response associated with DNA repair, cell cycle arrest, and cell death. Here in the present study we have focused on one of the most significant biological effects of US, i.e., DNA damage and discussed the underlying mechanisms and a unique cellular response. Read more>>>>>>>>>

Monday, 7 August 2017

A Forecast of Targeting Leukemia Stem Cells by Nanomedicine

Cancer Stem Cells (CSCs) are a subset of cancer cells with self-renewal, differentiation and tumor-initiating properties. They are considered as the leading cause of tumor initiation, promotion, and relapse in most types ofcancers.

Nanomedicine

The first experimental evidence for CSCs was given by Bonnet and Dick in 1997. They found that single CD34+CD38– Acute Myeloid Leukemia (AML) cell was able to initiate AML in NOD-SCID mice. Furthermore, this small subset population was found to be responsible for chemotherapy and radiotherapy resistance because CSCs have enhanced DNA repair ability, enriched anti-apoptotic proteins, improved drug efflux transporters, and are protected in specific microenvironment or niche. Therefore, these leukemia initiating cells (LIC) or leukemia Stem Cells (LSCs) are considered as a critical target for leukemia therapy. Subsequently, CSCs in solid tumors have been identified from brain, prostate, breast, colon, and pancreas cancer. Traditional cancer treatments, such as Chemotherapy and Radiotherapy, are cytotoxic to both normal and cancerous cells, which cause severe side effects, like bone marrow suppression, cardiomyopathy, and neurotoxicity. Read more>>>>>>>>

Thursday, 20 July 2017

Complex Treatment of Multiple Sclerosis Patients by Use of Fetal Stem Cells

Multiple Sclerosis (MS) is a chronic inflammatory disease of the Central Nervous System (CNS) ultimately leading to demyelination and axonal loss. This disease is complex andmultifactorial, but it seems that the main etiopathogenic event is presented by an aberrant response of the cells of immune system (T and B lymphocytes) to myelin proteins.

Multiple Sclerosis
Three forms of MS disease evolution exist. Approximately 80% of the patients have a Relapsing Remitting Multiple Sclerosis (RRMS) form; two thirds of them can likely develop a secondary progressive form over 10-15 years starting from MS disease onset. Around 20% of the patients can develop a progressive form of MS right from very onset, and such a disease is called Primary Progressive Multiple Sclerosis (PPMS). An average age of the patients with MS disease who were studied assembles 30 years. The main peak of morbidity due to MS can be attributed to the age of 20-40 years. Disease onset in the age of patients up to 16 years constitutes about 2.7% of cases. Read more>>>>>>>

Wednesday, 19 July 2017

Novel Combinations for Wound Healing: Chitosan/PVA Nano Fiber; Royal Jelly, Probiotic

Nowadays, Diabetes is one of the most common diseases in the world. These diseases and disorders of the problems for the patient and the health system create. One of the long term complications of diabetes is neuropathy, ornerve problems which are involved in diabetic foot ulcers and prevalence of this disorder in patients between 12 and 50 percent mentioned.

Wound Healing
Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both. Regarding the absence of sufficient efficacy of the available methods in diabetic wound healing, the use of alternative or complementary compounds has been considered. Probiotics, chitosan and royal jelly are among these compounds. Currently, after creating experimental diabetes with streptozotocin in rats, effects of probiotics (Lactobacillus casei), exopolysaccharide of Lactobacillus casei, chitosan Nano fibers and N-chromosome royal jelly were investigated on wound healing of the mentioned animals and were compared to common medications in the market. Read more>>>>>> 

Thursday, 6 July 2017

Gene-Directed Enzyme Pro-drug Therapy: A Promising Way for Cancer Treatment

Gene-directed protein prodrug medical aid (GDEPT) may be a promising strategy that aims to limit the general toxicity associate degreed improve the property of therapyuse through the expression of a factor that encodes associate degree catalystthat converts nontoxic prodrug into an activated cytotoxic agent. It offers a brand new approach to treating some cancers. Clinical trials are completed for brain and prostate cancers and also the initial product for post-surgical treatment of some brain tumors is awaiting selling approval. Recent innovations offer a glimpse into the doable future evolution of a brand new cistron medication.

journal of advancements in genetic engineering
GDEPT could be a two-step cistron medical aid approach wherever the cistron for a non-endogenous catalyst is directed to focus on tissues. First one is a factor of a far off catalyst is delivered to a tumour by a vector and second one is a prodrug is then administered that is property activated within the tumour site. Within the initiative, the cistron for a distant catalyst is run and is directed to the neoplasm, wherever it’s expressed by the utilization of specific promoters. Within the second step, injected prodrugs area unit activated by the foreign catalyst. The planning and synthesis of prodrugs able to bear protein activation in such systems is a vital part.The catalyst is expressed intracellularly wherever it’s able to activate an afterwards administered prodrug. It’s a promising new treatment for cancer therapy. The planning and synthesis of prodrugs able to bear animate thing enzymic activation by foreign genes in such systems is a vital part.(Read More) 

Tuesday, 4 July 2017

The Role of Cytologic Analysis in Follow-Up of Non-Muscle Invaisve Urothelial Cell Carcinoma in Relation to Cystoscopic Biopsy

Carcinoma of the urinary bladder is the most prevalent cancer in most African countries. In Egypt, bladder cancer represents the most common malignancy among Egyptian males and previously has been attributed to Schistosoma infection, a major risk factor for squamous cell carcinoma (SCC). Recently, urothelial carcinoma (UC) incidencehas been increasing while SCC has declined. About 85% of patients with urothelial bladder carcinoma present with nonmuscle invasive urothelial tumours (NMIUC) at first presentation, whereas the remaining 15% of primary tumours are already muscle invasive (MIUC). After being removed by transurethral resection (TUR), NMIUC will recur in up to 70% of patients and up to one third of pT1 tumours will eventually develop a progression to muscle invasive disease. Patients with bladder cancer therefore have to be monitored thoroughly for disease recurrence and progression. This makes bladder cancer one of the most expensive cancer types for the health care system.
journal of molecular biomarkers & diagnosis
Early detection of recurrent cancer is crucial to improve the treatment outcome. Consequently, regular follow-up for patients with NMIUC is mandatory. The tension on patients and the burden on health-care providers for life-long follow-up are great. There are classical methods for follow-up purposes as urine cytology and regular cystoscopy. Although cystoscopic biopsy is the most accurate diagnostic tool for detection of recurrent cancer, and currently is the standard of choice, cystoscopy may still miss tiny tumors, and also lead to false-negative results. Also, importantly, cystoscopy is invasive, and associated with morbidity, which is the main reason preventing patients from being regularly followed-up. Voided urine cytology is the most commonly used noninvasive follow-up diagnostic tool. In urine cytology, cells present in voided urine are examined and described as being positive or negative for the presence of malignant cells, atypical or having suspicious cells present.(Read more)

Monday, 3 July 2017

Clinical Relevance of Molecular Diagnosis in Patients with Congenital Hypothyroidism.

Congenital hypothyroidism, defined as the functional deficiency of thyroid hormones present at birth, occurs in approximately 1: 2,000 to 4,000 newborns. Thyroid hormones play an essential role in the maturation of the central nervous system. Congenital hypothyroidism results in severe neurodevelopmental impairment if untreated and, therefore constitutes the most common preventableendocrine cause of irreversible mental retardation. As clinical diagnosis of hypothyroidism in the newborn period is almost always overlooked, newborn screening programs seeking to identify elevated thyrotropin levels at birth are available to detect primary congenital hypothyroidism mainly. 
thyroid hormone biosynthesis
Significantly, early onset on levothyroxine replacement therapy virtually abolishes severe intellectual development.Congenital hypothyroidism is caused by genetic defects occurring at three different levels, including the hypothalamic-pituitary axis, the thyroid gland, and the peripheral tissues. Up to date, 30 monogenic forms of congenital hypothyroidism have been reported in individuals with thyroid dysgenesis, thyroid dyshormonogenesis, central and peripheral hypothyroidism, highlighting the genetic heterogeneity of the disease.(Read more)